GlassScriptPhysician profile
Arlene Barrett
NPI 1366750739
$2,520.79
in general payments reported to CMS, 2019-2025
16 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $466 · 2023: $286 · 2024: $181 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $367.13 | 2025 | Zeposia |
| Atricure, INC. | $284.33 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $246.30 | 2024-2025 | Rexulti |
| Ucb, INC. | $204.64 | 2022-2025 | Fintepla, Briviact |
| Amgen INC. | $194.87 | 2021 | |
| Livanova USA, INC. | $191.48 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Boston Scientific Corporation | $167.48 | 2023-2024 | Watchman Flx, Autocap Rx |
| Astrazeneca Pharmaceuticals LP | $143.38 | 2021-2025 | Wainua |
| Genentech USA, INC. | $127.00 | 2023 | |
| Amneal Pharmaceuticals LLC | $125.00 | 2025 | Crexont |
| Eisai INC. | $124.46 | 2025 | |
| Lilly USA, LLC | $122.55 | 2025 | |
| Abbvie INC. | $117.47 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $38.19 | 2021 | |
| Stryker Corporation | $35.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $30.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arlene Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.